MYTHY vs. ABBV
MYTHY (Mytilineos Holdings SA ADR) and ABBV (AbbVie Inc.) are both stocks. MYTHY operates in Conglomerates (Industrials), while ABBV operates in Drug Manufacturers - General (Healthcare).
Performance
MYTHY vs. ABBV - Performance Comparison
Loading charts...
Returns By Period
MYTHY
- 1D
- 0.00%
- 1M
- 0.00%
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
ABBV
- 1D
- -2.51%
- 1M
- -3.20%
- 6M
- 14.27%
- YTD
- 12.42%
- 1Y
- 32.53%
- 3Y*
- 23.28%
- 5Y*
- 20.99%
- 10Y*
- 18.94%
- ALL TIME*
- 20.35%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
ABBV AbbVie Inc. | $1.40B | $1.53B | $1.60B |
| $0.00 | $0.00 | $0.00 |
MYTHY vs. ABBV - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
MYTHY Mytilineos Holdings SA ADR | 0.00% |
ABBV AbbVie Inc. | 16.35% |
Fundamentals
MYTHY:
$8.19B
ABBV:
$443.24B
MYTHY:
€5.21B
ABBV:
$62.82B
MYTHY:
€667.88M
ABBV:
$46.15B
MYTHY:
€692.66M
ABBV:
$17.96B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MYTHY vs. ABBV — Risk / Return Rank
MYTHY
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
ABBV
MYTHY vs. ABBV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Mytilineos Holdings SA ADR (MYTHY) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MYTHY | ABBV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.26 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 2.14 | — |
| Martin ratioReturn relative to average drawdown | — | 4.73 | — |
Loading charts...
Drawdowns
MYTHY vs. ABBV - Drawdown Comparison
The maximum MYTHY drawdown since its inception was 0.00%, smaller than the maximum ABBV drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for MYTHY and ABBV.
Loading charts...
Drawdown Indicators
| MYTHY | ABBV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | 0.00% | -45.09% | +45.09% |
Max Drawdown (1Y)Largest decline over 1 year | — | -17.32% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -20.74% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -21.92% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -45.09% | — |
Current DrawdownCurrent decline from peak | 0.00% | -4.69% | +4.69% |
Average DrawdownAverage peak-to-trough decline | 0.00% | -10.64% | +10.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 7.81% | — |
Volatility
MYTHY vs. ABBV - Volatility Comparison
Loading charts...
Volatility by Period
| MYTHY | ABBV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 8.35% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 19.56% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 0.00% | 26.14% | -26.14% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 0.00% | 23.46% | -23.46% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 0.00% | 25.92% | -25.92% |
Dividends
MYTHY vs. ABBV - Dividend Comparison
MYTHY has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 2.72%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 2.72% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
MYTHY Mytilineos Holdings SA ADR | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
MYTHY vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Mytilineos Holdings SA ADR and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MYTHY vs. ABBV - Profitability Comparison
MYTHY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Mytilineos Holdings SA ADR reported a gross profit of 180.41M and revenue of 1.80B. Therefore, the gross margin over that period was 10.0%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.
MYTHY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Mytilineos Holdings SA ADR reported an operating income of 142.56M and revenue of 1.80B, resulting in an operating margin of 7.9%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.
MYTHY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Mytilineos Holdings SA ADR reported a net income of 126.88M and revenue of 1.80B, resulting in a net margin of 7.0%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.
Find the right allocation for MYTHY and ABBV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer